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Abstract
Objective—To test the hypotheses that reported asthma prevalence is higher among insured than
uninsured children and that insurance-based differences in asthma diagnosis, treatment, and
healthcare utilization are associated with disease severity.
Data Sources—National Health and Nutrition Examination Survey, 2003–2008.
Study Design—We used multivariate logistic regression to examine the relationship between
insurance and asthma symptom severity with asthma diagnosis, treatment, and acute care
utilization.
Principal Findings—In multivariate analysis, insured children had greater odds of reporting a
current diagnosis of asthma than uninsured children (Odds Ratio [OR]=2.08, 95% Confidence
Interval [CI] 1.47–2.94). When interactions between insurance and asthma impairment were
included, insurance was associated with greater odds of diagnosis among children with
intermittent (OR=4.08, 95%CI 1.57–10.61), but not persistent, symptoms. Among children with
intermittent symptoms, insurance was associated with inhaled corticosteroid use (OR=4.51,
95%CI 1.18–17.24) and asthma-related acute care utilization (OR=5.21, 95%CI 1.21–23.53);
these associations were non-significant among children with persistent symptoms.
Conclusion—Being insured increases only the likelihood that a child with intermittent, not
persistent, asthma symptoms will receive an asthma diagnosis and control medication, and may
not reduce acute care utilization. Although universal insurance may increase detection and
management of undiagnosed childhood asthma, theorized cost savings from reduced acute care
utilization might not materialize.
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Providing health insurance to uninsured children with known asthma can result in improved
asthma outcomes, including fewer asthma attacks and less frequent asthma-related
hospitalizations and emergency department (ED) visits (Szilagyi et al. 2006). In addition,
there may be a large reservoir of symptomatic but undiagnosed asthma in children, ranging
from 12% to 17% of all children, especially in urban, low-income, and minority populations
(Clark et al. 2010; Joseph et al. 2005; Mvula et al. 2005; Quinn et al. 2006; Webber et al.
2002; Yeatts et al. 2003a; Yeatts et al. 2003b).
The Children’s Health Insurance Program Reauthorization Act (CHIPRA) and the
Affordable Care Act (ACA) may lead to a large number of uninsured children becoming
insured (Kaiser Family Foundation 2010; Sebelius 2010). Few data explore the relationship
between health insurance and asthma diagnosis and outcomes for undiagnosed children. One
of the few published studies found that symptomatic children in Bronx, New York schools
with an asthma diagnosis were more likely to have health insurance than those without an
asthma diagnosis (Webber et al. 2002).
Even if insurance status does increase the chance of an asthma diagnosis, whether that
diagnosis leads to reduced asthma-related acute care utilization (i.e., acute care for
exacerbation of asthma symptoms) is unclear. Previous studies have documented lower rates
of ED and physician visits for wheezing, and fewer missed school days among undiagnosed
symptomatic children compared with diagnosed asthmatic children (Gerald et al. 2009;
Joseph et al. 2005; Yeatts et al. 2003b). It is plausible that enhanced diagnosis may increase
asthma-related acute care utilization rather than prevent it. Children with undiagnosed
asthma may be under-utilizing acute care services, for reasons related to poor access to care
or inadequate knowledge regarding asthma. Another explanation may be that additional
utilization of services for children diagnosed with asthma is related less to clinical need than
to patient and physician factors (Emanuel, and Fuchs 2008).
The purpose of this study was to examine the differences in asthma diagnosis and outcomes
among children with and without insurance, and to determine the association between health
insurance and asthma diagnosis, impairment level, and asthma-related outcomes among
children with asthma symptoms. Accounting for factors known to be associated with asthma
prevalence (e.g., race/ethnicity), we hypothesized that uninsured children would have a
lower reported asthma prevalence than insured children (due to less screening and
detection), and that this disparity would be seen primarily in children with intermittent rather
than persistent symptoms (because children with persistent symptoms would be more likely
to be detected regardless of health insurance status). Additionally, we hypothesized that
differences in acute care utilization would be modest, given the tendency of greater
screening to detect intermittent rather than persistent asthma.
METHODS
We used NHANES, a population-based survey of U.S. households conducted by the
National Center for Health Statistics. NHANES uses a complex, multistage probability
sample of the U.S. civilian, non-institutionalized population. We used the following
questionnaire components: 1) Respiratory Health and Disease, 2) Medical Conditions, 3)
Hospital Utilization and Access to Care, 4) Prescription Medications, and 5) Demographics.
Data from surveys in 2003–2004, 2005–2006, and 2007–2008 were aggregated for our
analysis. For children <16, data are reported by an adult in the household, usually a parent or
guardian. Our analysis is restricted to 11,719 children ages 1–17.
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We used NHANES to assess asthma diagnosis, symptoms, inhaled corticosteroid use, and
asthma exacerbation-related acute care visits (at a doctor’s office or ED).
Asthma Diagnosis—Participants were asked whether a doctor or other health
professional had ever told them that they have asthma and, if so, whether they still had the
diagnosis. Only participants who answered yes to both questions were considered to have a
current diagnosis of asthma, henceforth referred to simply as “diagnosis” of asthma.
Asthma Severity—The National Heart, Lung, and Blood Institute (NHLBI) Asthma
Guidelines (National Heart Lung and Blood Institute 2007) categorize children with asthma
symptoms as intermittent or persistent, based on the level of impairment and risk. The
guidelines specify impairment and risk criteria for distinguishing intermittent from persistent
asthma in children not currently on asthma control medication. For children ≥5 years of age,
those with intermittent asthma use a short-acting beta2 agonist <3 days/week, have asthma
symptoms <3 days/week, have <3 nighttime awakenings/month, have no interference with
normal activity, and have <2 asthma exacerbations requiring oral steroids per year. The
NHLBI guidelines differ for children <5 in that children with any nighttime awakenings,
with >1 exacerbation requiring oral steroids in 6 months, and, when asthma risk factors are
present, with >3 wheezing episodes/year are considered to have persistent asthma.
NHANES does not include all of this information on asthma impairment and risk. Therefore,
we used only the NHANES respiratory symptoms questions that matched reasonably well
with NHLBI criteria (see supplementary table). We used the following criteria to categorize
children with varying levels of asthma severity: children <5 years old were categorized as
having persistent asthma symptoms if they reported wheezing in the past 12 months and
reported any of the following in the past 12 months: 1) any limitation of activity due to
wheezing, 2) >3 wheezing episodes, or 3) any sleep disturbances from wheezing. Children
<5 years old who reported wheezing but did not report one of those impairments were
categorized as having intermittent symptoms. Children who reported not wheezing at all in
the past 12 months were categorized as having no symptoms of asthma. For children ≥5
years old, criteria were the same except that sleep disturbances needed to occur at least
weekly to be considered persistent asthma (when sleep disturbances are reported, NHANES
only asks if they occur <1 night per week or ≥1 night per week), and the number of
wheezing attacks was not considered.
Medications and Asthma-Related Acute Visits—Participants were asked the names
of prescribed medications taken in the past 30 days. We considered only the following
asthma-related medication categories: 1) inhaled corticosteroids (alone or in combination
with long-acting bronchodilators), 2) short-acting bronchodilators, and 3) other long-term
control medications, including long-acting bronchodilators (without corticosteroids),
leukotriene inhibitors, and mast cell stabilizers. Each medication category was coded as 1 if
the child reported taking the medication in the past 30 days. Participants also provided the
number of times in the past 12 months they visited a doctor’s office or ED for an “attack of
wheezing or whistling.”
Demographics—We used the following NHANES demographic data: child age, child
gender, child race/ethnicity (Hispanic, non-Hispanic White, non-Hispanic Black, and other),
child insurance status (insured versus uninsured), and family income as a percentage of the
family composition-adjusted federal poverty level. Insurance status was initially categorized
as uninsured, publicly-insured (Medicaid and SCHIP), privately-insured, and other. Because
differences between (1) uninsured and publicly-insured and (2) uninsured and privately-
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insured were both significant in the same direction for our main outcome, and because
previous literature has documented that publicly- and privately-insured children often
receive similar quality of primary care (with publicly-insured children receiving even higher
quality care in some cases) (Berdahl et al. 2010; Newacheck et al. 2009; Perry, and Kenney
2007), we combined publicly-and privately-insured children into a single insured category.
Statistical Analysis
All analyses used survey-specific weights to account for potential non-response bias and
non-coverage of households without a telephone, and to provide national estimates.
Analyses were conducted using Stata/SE version 11 (StataCorp LP, College Station, TX) to
adjust for the complex survey design. To account for potential bias caused by item non-
response, we used imputation by chained equations (Royston 2009). With the exception of
family poverty level, no variable used in our imputations and analyses was missing >1% of
observations.
Using logistic regression, we estimated the odds of having a diagnosis of asthma by
insurance status, with interaction terms between insurance status and each level of symptom
impairment (no symptoms, intermittent asthma symptoms, persistent asthma symptoms).
Using logistic regression and controlling for demographic variables, we examined whether
insured children, regardless of asthma diagnosis, had higher odds of reporting any,
intermittent, or persistent asthma symptoms.
NHLBI classification of severity as determined by symptom impairment and risk only
applies to children not currently taking long-term control mediations. For children on long-
term control medications, lack of symptom impairment might simply reflect adequacy of
control. Since this information was not available through NHANES, we conducted
sensitivity analyses to determine whether our multivariate logistic regression results would
be altered by limiting our analyses to children not currently on control medications.
Next, we used logistic regression to examine the odds of children with and without
insurance a) having used an inhaled corticosteroid in the past 30 days, and b) having a
doctor’s office or ED visit in the past 12 months for an asthma attack. In these multivariate
regression models, we included demographic variables as covariates. We also conducted
additional sensitivity analyses to examine whether any difference detected in the odds of
having an asthma exacerbation-related acute visit would be affected by the inclusion of
controller asthma medication use in our model.
RESULTS
Sample Characteristics
Table 1 describes the characteristics of the 11,714 children under the age of 18 in the
sample. Fifty-nine percent of children were non-Hispanic White, 15% were non-Hispanic
Black, and 19% were Hispanic. Eleven percent of children were uninsured, and 45% of
children had a household income under 200% of the federal poverty level (FPL). Ten
percent had a current diagnosis of asthma, 13% reported wheezing in the past 12 months,
7% reported sleep disturbances due to wheezing, and 6% reported that wheezing limits their
activity. Two percent of children were currently taking an inhaled corticosteroid, and 3%
were taking another long-term asthma control medication (long-acting beta-agonists and
immunomodulaters). Of note, very few children without a current diagnosis of asthma
reported using these asthma-related medications (e.g., .04% for inhaled corticosteroids)
(data not shown). Using our categorization for symptom severity, 87% reported no
symptoms, 5% reported having intermittent symptoms, and 8% reported having persistent
symptoms.
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Among children with a diagnosis of asthma (10%; n=1214), 6% (n=104) were uninsured,
and 94% (n=1110) were insured. Forty-nine percent (n=721) of children with asthma
symptoms (intermittent or persistent) did not have a diagnosis of asthma. Among all
symptomatic but undiagnosed children, 11% were uninsured (Table 2).
Asthma Diagnosis
In multivariate regressions controlling for demographics, the odds of having a diagnosis of
asthma were 2.08 times greater for insured versus uninsured children (95% CI 1.47–2.94).
When interactions between insurance and asthma impairment were included, however, the
association held true only for children with no or intermittent symptoms (Table 3). Insured
children with no and intermittent asthma symptoms, respectively, had 2.01 (95% CI 1.23–
3.31) and 4.08 (95% CI 1.57–10.61) times the odds of having an asthma diagnosis compared
to uninsured children. Among those with persistent symptoms the association was not
significant (OR 1.45, 95% CI 0.88–2.39).
In a sensitivity analysis (not shown), we repeated these multivariate regressions using only
children who were currently not taking any long-term asthma control medications (NHLBI
severity classifications only apply to children not taking long-term control medications). Our
results were similar to the analysis with the full sample of children; insured children were
more likely to have a diagnosis of asthma (AOR 1.88, 95% CI 1.29, 2.73), and this
association was also true for insured children with no (AOR 1.73, 95% CI 1.03–2.90) and
intermittent symptoms (AOR 3.49, 95% CI 1.31–9.30), but not for children with persistent
symptoms (AOR 1.40, 95% CI 0.80–2.44).
The fact that insured children were more likely to be diagnosed with asthma than uninsured
children could not be attributed to a greater reported prevalence of asthma symptoms. In
multivariate regressions controlling for both demographics and asthma medication use (not
shown), insured children were no more likely to report any (OR 1.05, 95% CI 0.75–1.46),
intermittent (OR 0.88, 95% CI 0.54–1.44), or persistent (OR 1.23, 95% CI 0.89–1.70)
asthma symptoms than uninsured children.
Inhaled Corticosteriod Use
In multivariate regressions controlling for demographics (Table 4), insured children with no
or intermittent symptoms had, respectively, 10.54 (95% CI 2.24–49.71) and 4.51 (95% CI
1.18–17.24) times greater odds of using inhaled corticosteroids as uninsured children.
Among children with persistent symptoms, however, no significant difference was detected
(OR 1.18, 95% CI 0.53–2.61).
Asthma-Related Outpatient and ED Visits
In multivariate regressions controlling for demographics (Table 5), insured children with
intermittent symptoms were more likely than uninsured children to have had an acute care
visit at a doctor’s office or ED for an asthma attack (OR 5.21, 95% CI 1.21–22.53). This
difference was not found among children with persistent asthma symptoms (OR 1.03, 95%
CI 0.42–2.52). In sensitivity analyses, we found similar results when including inhaled
corticosteroid use as a covariate in our model.
DISCUSSION
Insured children with intermittent asthma symptoms have a greater likelihood of being
diagnosed with asthma and receiving long-term inhaled corticosteroid treatment than those
without insurance. Further, insured children with intermittent symptoms are also more likely
to make acute outpatient and ED visits for asthma attacks. These differences in asthma
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diagnosis, treatment, and utilization by health insurance were not observed for those with
persistent symptoms.
Our findings suggest that, although health insurance may be an important factor in asthma
diagnosis among children with intermittent symptoms, it may play a much smaller role in
asthma diagnosis among children with persistent symptoms. Insured children with persistent
symptoms are about as likely to have a diagnosis of asthma as uninsured children with
similar symptoms. One likely explanation is that, because children with persistent symptoms
have a higher level of need for acute asthma care, they tend to present to clinics, urgent care
centers, and EDs regardless of their insurance status, thus creating similar opportunities for
diagnosis.
Among children with intermittent asthma symptoms, insured children were more likely than
uninsured children not only to take an inhaled corticosteroid, but also to have had a recent
acute care visit or ED visit for “wheezing attacks.” This finding is somewhat
counterintuitive, given that inhaled corticosteroids have been shown to reduce acute care
utilization. There are at least three plausible explanations for this observation. First, some
uninsured children may have a similar need for acute care as insured children but may be
unable to receive it consistently because they do not have insurance (Hoffman, and Paradise
2008; Kenney 2007; Stoddard, St. Peter, and Newacheck 1994). Alternatively, some
children with intermittent symptoms may over-utilize acute care services once they are
provided with both insurance and a diagnosis; for instance, a diagnosis of asthma may
sensitize parents and heighten their anxiety about minor symptoms. Third, the increased
acute care utilization may have occurred before the patient began using the inhaled
corticosteroid.
Our findings suggest that there may be a significant “reservoir” of undiagnosed asthmatic
children, especially among those who lack health insurance. The benefits of identifying
these children, however, are unclear—they are more likely to have intermittent symptoms,
which may not benefit greatly from control therapy. As access to insurance expands through
health care reform, asthma diagnoses may increase from their current plateau, and we may
see additional increases in inhaled corticosteroid use. Such increases, however, may incur a
cost that might not greatly improve societal health.
This study has several important limitations. First, based on the age of the participant (1–15
years versus 16–17 years), the data were collected via parent-report or self-report. We do not
have data on differences in the accuracy of the reporting methods based on these age groups
for reporting asthma-related symptoms, medication, and utilization. Second, our findings are
based on cross-sectional data, and we are unable to determine the temporal ordering of
events. For example, some children with no or intermittent symptoms were taking inhaled
corticosteroids, and possibly had persistent asthma that was now well-controlled on inhaled
corticosteroids. However, our sensitivity analysis suggested that our findings were similar
when restricted to children not currently on a control medication. Next, our analysis used a
limited number of covariates that could have missed important confounders. For example,
our study confirms previous studies showing that asthma diagnosis and symptoms vary by
race/ethnicity (Akinbami, Rhodes, and Lara 2005; Crocker et al. 2009; Flores, and The
Committee on Pediatric Resarch 2010; Gold, and Wright 2005; Quinn et al. 2006). Some
evidence suggests that much of this disparity can be attributed to socioeconomic factors
(Litonjua et al. 1999; Smith et al. 2005); however, other factors related to race/ethnicity,
such as stress, also appear to be critical (Gold, and Wright 2005; Williams, Sternthal, and
Wright 2009). Finally, we were unable to use NHLBI guidelines to categorize asthma
severity. Some of the indicators of symptom severity that we used are also in the NHLBI
classification, but there are also some indicators from NHLBI that were not available in the
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NHANES dataset. A side-by-side comparison of the criteria used in this study compared
with the criteria used in the NHLBI 2007 guidelines is available as a supplementary table.
In conclusion, we found that having health insurance is associated with an increased
likelihood that a child with intermittent asthma symptoms will receive an asthma diagnosis
and asthma control medication, but is not associated with improvements in asthma-related
acute care utilization. We also found that, for children with persistent symptoms, having
health insurance is not associated with diagnosis, treatment, or utilization. These findings
suggest that while increasing access to insurance could lead to the identification of more
children with intermittent asthma symptoms, benefits with respect to acute care utilization
remain unclear. CHIPRA and expanded Medicaid coverage of parents under the ACA may
lead to many previously uninsured children in the U.S. becoming insured (Kaiser Family
Foundation 2010; Sebelius 2010). This increase in the proportion of insured children may
reduce the number of undiagnosed children with intermittent asthma symptoms and ensure
that they receive more appropriate treatment; large cost savings from reduced acute care
utilization, however, may not be a realistic expectation. Potential long-term benefits and
costs of detecting and treating undiagnosed asthma in these newly insured children should
be explored.
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Table 1
Sample Characteristics (n=11,714)
General Characteristics % N
Child Gender- Female 49 5803
Child Race/Ethnicity
 Hispanic 19 4258
 Non-Latino Black 15 3505
 Non-Hispanic Other 7 621
 Non-Hispanic White 59 3330
Child Age
 <5 years 24 3271
 5–11 40 4074
 12–18 37 4369
Income as % FPL
 0–99% 22 3798
 100–199% 23 3137
 200–399% 30 2990
 ≥400% 25 1789
Health Insurance
 Uninsured 11 1670
 Private 56 4945
 Medicaid/SCHIP 22 3525
 Other (Military, Indian Health Service, other*) 10 1502
Survey Year
 2003–2004 33 4022
 2005–2006 33 4256
 2007–2008 33 3436
Asthma-related characteristics
Has a current diagnosis of asthma 10 1214
Wheeze in past year 13 1540
Sleep disturbance
 Never 93 10803
 <1/week 4 480
 At least 1/week 3 431
Activity Limitation, any 6 679
Currently taking ICS 2 290
Currently taking other long-term controller medication* 3 245
Currently taking short-acting bronchodilator 5 577
Asthma Symptom Severity
 No symptoms 87 10174
 Intermittent symptoms 5 562
 Persistent symptoms 8 978













Coker et al. Page 10
*
includes long acting bronchodilators and immunomodulators
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Table 2
Child Insurance Status by Asthma Diagnosis
Insured, % (n) Uninsured, % (n)
Current asthma diagnosis 94 (1110) 6 (104)
Undiagnosed, symptomatic 89 (647) 11 (74)
Undiagnosed, asymptomatic 88 (8287) 12 (1492)
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Table 3
Adjusted odds ratio of having a current asthma diagnosis by insurance status and disease impairment.
Predictor Unadjusted Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI)
Insured (Uninsured at each of 3 symptoms levels is reference category)
  With no asthma symptoms 1.91 (1.16–3.14) 2.01 (1.23–3.31)
  With intermittent asthma symptoms 3.57 (1.34–9.51) 4.08 (1.57–10.61)
  With persistent asthma symptoms 1.39 (0.81–2.40) 1.45 (0.88–2.39)
Household Income as % of FPL
 0–99% Reference Reference
 100–199% 0.86 (0.65–1.14) 0.77 (0.54–1.09)
 200–399% 0.90 (0.67–1.20) 0.83 (0.58–1.19)
 ≥400% 0.84 (0.66–1.06) 0.77 (0.54–1.08)
Race/Ethnicity
  White non-Hispanic Reference Reference
  Hispanic 0.85 (0.72–1.02) 1.03 (0.79–1.35)
  Black non-Hispanic 1.70 (1.44–2.01) 1.84 (1.49–2.27)
  Other 0.81 (0.51–1.30) 1.01 (0.62–1.64)
Child age (years) 1.04 (1.03–1.06) 1.11 (1.09–1.12)
Child gender- female 0.86 (0.73–1.01) 0.98 (0.81–1.18)
Survey wave
  2003–04 Reference Reference
  2005–06 1.20 (1.01–1.42) 1.29 (1.02–1.63)
  2007–08 1.14 (0.96–1.37) 1.28 (0.96–1.69)
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Table 4
Adjusted odds ratio of using inhaled corticosteroids (past 30 days) by insurance status and disease impairment.
Predictor Unadjusted Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI)
Insured (Uninsured at each of 3 symptoms levels is reference category)
  With no asthma symptoms 11.21 (2.36–53.19) 10.54 (2.24–49.71)
  With intermittent asthma symptoms 4.96 (1.36–18.08) 4.51 (1.18–17.24)
  With persistent asthma symptoms 1.21 (0.55–2.64) 1.18 (0.53–2.61)
Household Income as % of FPL
 0–99% Reference Reference
 100–199% 0.83 (0.50–1.38) 0.79 (0.46–1.35)
 200–399% 0.83 (0.55–1.26) 0.79 (0.50–1.27)
 ≥400% 1.09 (0.70–1.70) 1.07 (0.65–1.78)
Race/Ethnicity
  White non-Hispanic Reference Reference
  Hispanic 0.73 (0.51–1.04) 0.88 (0.60–1.29)
  Black non-Hispanic 1.39 (1.03–1.87) 1.27 (0.94–1.72)
  Other 0.51 (0.21–1.24) 0.58 (0.25–1.36)
Child age (years) 1.00 (0.97–1.03) 1.03 (0.99–1.06)
Child gender- female 0.79 (0.56–1.10) 0.91 (0.64–1.30)
Survey wave
  2003–04 Reference Reference
  2005–06 1.85 (1.34–2.56) 1.90 (1.39–2.59)
  2007–08 1.84 (1.28–2.65) 1.99 (1.33–2.98)
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Table 5
Adjusted odds ratio of having a doctor’s visit or emergency department visit for an asthma attack (past 12
months) by insurance status and disease impairment.
Predictor Unadjusted Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI)
Insured (Uninsured at each of 3 symptoms levels is reference category)
  With no asthma symptoms 1.87 (0.23–14.97) 2.20 (0.28–17.36)
  With intermittent asthma symptoms 5.26 (1.17–23.65) 5.21 (1.21–22.53)
  With persistent asthma symptoms 0.95 (0.41–2.21) 1.03 (0.42–2.52)
Household Income as % of FPL
 0–99% Reference Reference
 100–199% 0.91 (0.62–1.33) 0.93 (0.62–1.39)
 200–399% 0.52 (0.34–0.79) 0.57 (0.36–0.91)
 ≥400% 0.52 (0.31–0.89) 0.68 (0.39–1.19)
Race/Ethnicity
  White non-Hispanic Reference Reference
  Hispanic 1.30 (0.83–2.02) 1.43 (0.86–2.38)
  Black non-Hispanic 2.77 (1.92–3.98) 2.44 (1.65–3.59)
  Other 0.99 (0.45–2.16) 1.27 (0.54–3.01)
Child age (years) 0.97 (0.94–1.00) 1.02 (0.98–1.05)
Child gender- female 0.59 (0.40–0.88) 0.74 (0.48–1.13)
Survey wave
  2003–04 Reference Reference
  2005–06 1.11 (0.73–1.69) 1.15 (0.79–1.68)
  2007–08 0.94 (0.61–1.46) 0.98 (0.61–1.57)
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